ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 80 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 4.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $31,392 | -25.3% | 28,800 | 0.0% | 0.02% | -28.0% |
| Q4 2022 | $42,048 | +5.1% | 28,800 | -21.7% | 0.02% | -51.9% |
| Q3 2022 | $40,000 | -43.7% | 36,800 | -12.0% | 0.05% | -32.5% |
| Q2 2022 | $71,000 | -80.8% | 41,800 | -57.5% | 0.08% | -64.7% |
| Q4 2021 | $369,000 | -28.6% | 98,450 | -1.5% | 0.22% | -31.9% |
| Q3 2021 | $517,000 | +123.8% | 99,950 | +84.2% | 0.32% | +128.6% |
| Q2 2021 | $231,000 | +16.1% | 54,250 | +45.1% | 0.14% | -0.7% |
| Q1 2021 | $199,000 | +111.7% | 37,400 | +113.7% | 0.14% | +58.4% |
| Q4 2020 | $94,000 | – | 17,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |